内幕交易被披露。《投资者网》蔡俊石药集团（01093.HK，下称“公司”）内部的隐秘角落，被揭开。11月，公司公告执行董事潘卫东收到中国证监会出具的《行政处罚决定书》。事件源于两年前的一次重组交易，监管层的披露则将交易牌桌下的操作曝光。实际上，通过一系列的资产注入与BD交易，石药系整体市值超1000亿元。但硬币的另一面，公司传统核心业务承压，创新药兑现仍有时日的困境也存在。千亿市值的焦虑，展现了...
Source Link内幕交易被披露。《投资者网》蔡俊石药集团（01093.HK，下称“公司”）内部的隐秘角落，被揭开。11月，公司公告执行董事潘卫东收到中国证监会出具的《行政处罚决定书》。事件源于两年前的一次重组交易，监管层的披露则将交易牌桌下的操作曝光。实际上，通过一系列的资产注入与BD交易，石药系整体市值超1000亿元。但硬币的另一面，公司传统核心业务承压，创新药兑现仍有时日的困境也存在。千亿市值的焦虑，展现了...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.